Litcius/Paper detail

Targeted therapy of atherosclerosis by zeolitic imidazolate framework-8 nanoparticles loaded with losartan potassium <i>via</i> simultaneous lipid-scavenging and anti-inflammation

Jie Sheng, Ziyue Zu, Yugang Zhang, Haitao Zhu, Jianchen Qi, Tao Zheng, Ying Tian, Long Jiang Zhang

2022Journal of Materials Chemistry B24 citationsDOI

Abstract

Atherosclerosis (AS) is a condition associated with dysfunctional lipid metabolism and an inflammatory immune microenvironment that remains the leading cause of severe cardiovascular events.

Topics & Concepts

Zeolitic imidazolate frameworkNanoparticleImidazolateMaterials scienceLosartan PotassiumLosartanPotassiumInflammationScavengingSimvastatinPharmacologyChemistryNanotechnologyAngiotensin IIBiochemistryMedicineInorganic chemistryInternal medicineMetallurgyAdsorptionOrganic chemistryMetal-organic frameworkAntioxidantReceptorAutophagy in Disease and TherapyMetal-Organic Frameworks: Synthesis and ApplicationsAdvanced Nanomaterials in Catalysis
Targeted therapy of atherosclerosis by zeolitic imidazolate framework-8 nanoparticles loaded with losartan potassium <i>via</i> simultaneous lipid-scavenging and anti-inflammation | Litcius